Testing the long term stability of vancomycin ophthalmic solution

International Journal of Pharmaceutical Compounding

Volumn 12, Issue 5, 2008, Pages 456-459

  McLellan, Christine ^a   Ngo, Van ^a   Pasedish, Sophia ^b   Dohlman, Claes H ^a  

^a MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

^b Ameridose   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZALKONIUM; ENDOTOXIN; EYE DROPS; VANCOMYCIN;

ANTIBIOTIC PROPHYLAXIS; CONTACT LENS; DRUG FORMULATION; DRUG POTENCY; DRUG SOLUTION; DRUG STABILITY; EXPIRATION DATE; FREEZING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; KERATOPROSTHESIS; MICROBIAL GROWTH; PH; REVIEW; ROOM TEMPERATURE; STORAGE TEMPERATURE;

EID: 69749096295     PISSN: 10924221     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (13)

1. Nouri M, Terada H, Alfonso EC et al. Endophthalmitis after keratoprosthesis: incidence, bacterial causes, and risk factors. Arch Ophthalmol 2001; 119: 484-489.
2. Dohlman CH, Nouri M. Keratoprosthesis surgery. In: Foster CS, Azar DT, Dohlman CH, eds. Smolin and Thoft's The Cornea. 4th ed. Philadelphia: Lippincott, Williams & Wilkins; 2005: 1085-1098.
3. Dohlman CH, Barnes S, Nouri M et al. Preventing endophthalmitis in keratoprosthesis: Prophylactic antibiotic regimens. Invest Ophthalmol Vis Sci 2003; 1455.
4. Trissel LA. Handbook on Injectable Drugs. 13th ed. Bethesda, MD: American Society of Health-System Pharmacists; 2005: 1446-1459.
5. United States Pharmacopeial Convention, Inc. USP Pharmacists' Pharmacopeia. Rockville, MD: US Pharmacopeial Convention, Inc.; 2005.
6. Noecker, R. Effects of common ophthalmic preservatives on ocular health. Adv in Therapy 2001; 18(5): 205-215.
7. Asbell PA, Potapova N. Effects of topical antiglaucoma medications on the ocular surface. The Ocul Surf. 2005; 3(1): 27-40.
8. Crawford SY, Dombrowski SR. Extemporaneous compounding activities and the associated informational needs of the pharmacists. Am J Hosp Pharm 1991; 48(6):1205-1210.
9. Reynolds LA. Guidelines for the preparation of sterile ophthalmic products. Am J Hosp Pharm 1991; 48(11): 2438-2439.
10. Reynolds LA, Closson RG. Extemporaneous Ophthalmic Preparations. Vancouver, WA: Applied Therapeutics; 1993: 313-324.
11. ASHP Council on Professional Affairs. ASHP technical assistance bulletin on pharmacy-prepared ophthalmic products. Am J Hosp Pharm 1993; 50(7): 1462-1463.
12. Fuhrman LC Jr, Stroman RT. Stability of vancomycin in an extemporaneously compounded ophthalmic solution. Am J Health Syst Pharm 1998; 55(13): 1386-1388.
13. Charlton JF, Dalla KP, Kniska A. Storage of extemporaneously prepared ophthalmic antimicrobial solutions. Am J Health Syst Pharm 1998; 55(5): 463-466.